Novel anticancer combination therapies using replication-selective oncolytic adenoviruses and chemotherpeutics: investigating cell death mechanisms.
(Elective)
BSC VET PATH REPORT 2010 NO. 2
1 available
Description
Copies
| Location | Call Number | Status |
|---|---|---|
| Hawkshead Library - Stack | BSC VET PATH REPORT 2010 NO. 2 | On Shelf |
Citations
Hammaren Busch, K. (2010). Novel anticancer combination therapies using replication-selective oncolytic adenoviruses and chemotherpeutics: investigating cell death mechanisms . University of London (The Royal Veterinary College).
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)Hammaren Busch, Kristina. 2010. Novel Anticancer Combination Therapies Using Replication-selective Oncolytic Adenoviruses and Chemotherpeutics: Investigating Cell Death Mechanisms. London: University of London (The Royal Veterinary College).
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)Hammaren Busch, Kristina. Novel Anticancer Combination Therapies Using Replication-selective Oncolytic Adenoviruses and Chemotherpeutics: Investigating Cell Death Mechanisms London: University of London (The Royal Veterinary College), 2010.
Harvard Citation (style guide)Hammaren Busch, K. (2010). Novel anticancer combination therapies using replication-selective oncolytic adenoviruses and chemotherpeutics: investigating cell death mechanisms. London: University of London (The Royal Veterinary College).
MLA Citation, 9th Edition (style guide)Hammaren Busch, Kristina. Novel Anticancer Combination Therapies Using Replication-selective Oncolytic Adenoviruses and Chemotherpeutics: Investigating Cell Death Mechanisms University of London (The Royal Veterinary College), 2010.